日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

智能启动:利妥昔单抗、来那度胺和伊布替尼治疗新诊断的大B细胞淋巴瘤患者

Westin, Jason; Davis, R Eric; Feng, Lei; Hagemeister, Fredrick; Steiner, Raphael; Lee, Hun Ju; Fayad, Luis; Nastoupil, Loretta; Ahmed, Sairah; Rodriguez, Alma; Fanale, Michelle; Samaniego, Felipe; Iyer, Swaminathan P; Nair, Ranjit; Oki, Yasuhiro; Fowler, Nathan; Wang, Michael; Ma, Man Chun John; Vega, Francisco; McDonnell, Timothy; Pinnix, Chelsea; Griffith, Donna; Lu, Yang; Tewari, Sanjit; Sun, Ryan; Scott, David W; Flowers, Christopher R; Neelapu, Sattva; Green, Michael R

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

一项评估来那度胺、奥妥珠单抗联合CHOP方案治疗新诊断弥漫性大B细胞淋巴瘤的1/2期临床研究。

Cherng, Hua-Jay J; Alig, Stefan K; Oki, Yasuhiro; Nastoupil, Loretta J; Fayad, Luis; Neelapu, Sattva S; Turturro, Francesco; Hagemeister, Fredrick; Craig, Alexander F M; Macaulay, Charles W; Rodriguez, Maria Alma; Lee, Hun Ju; McDonnell, Timothy J; Flowers, Christopher R; Vega, Francisco; Green, Michael R; Feng, Lei; Kurtz, David M; Alizadeh, Ash A; Davis, R Eric; Westin, Jason R

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

既往未接受治疗的晚期经典型霍奇金淋巴瘤老年患者(≥60岁):来自III期ECHELON-1研究的详细分析

Evens, Andrew M; Connors, Joseph M; Younes, Anas; Ansell, Stephen M; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J; Oki, Yasuhiro; Grigg, Andrew; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma

贝利司他联合标准环磷酰胺、多柔比星、长春新碱和泼尼松作为新诊断外周T细胞淋巴瘤患者的一线治疗方案

Johnston, Patrick B; Cashen, Amanda F; Nikolinakos, Petros G; Beaven, Anne W; Barta, Stefan Klaus; Bhat, Gajanan; Hasal, Steven J; De Vos, Sven; Oki, Yasuhiro; Deng, Changchun; Foss, Francine M

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

一项针对复发/难治性侵袭性B细胞和T细胞淋巴瘤的alisertib和romidepsin的1期临床试验

Strati, Paolo; Nastoupil, Loretta J; Davis, Richard E; Fayad, Luis E; Fowler, Nathan; Hagemeister, Fredrick B; Kwak, Larry; Oki, Yasuhiro; Wang, Michael; Westin, Jason; Ruben, Charnelle E; Wesson, Emily T; Piekarz, Richard; Fanale, Michelle A; Lee, Hun Ju

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

Tenalisib (RP6530)(一种双重 PI3K δ/γ 抑制剂)治疗复发/难治性 T 细胞淋巴瘤患者的 I/Ib 期研究

Huen, Auris; Haverkos, Bradley M; Zain, Jasmine; Radhakrishnan, Ramchandren; Lechowicz, Mary Jo; Devata, Sumana; Korman, Neil J; Pinter-Brown, Lauren; Oki, Yasuhiro; Barde, Prajak J; Nair, Ajit; Routhu, Kasi Viswanath; Viswanadha, Srikant; Vakkalanka, Swaroop; Iyer, Swaminathan P

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

ABVD联合利妥昔单抗对比ABVD单药治疗晚期高危经典型霍奇金淋巴瘤:一项随机II期研究

Strati, Paolo; Fanale, Michelle A; Oki, Yasuhiro; Turturro, Francesco; Fayad, Luis E; Bartlett, Nancy L; Gladstone, Douglas E; Kasamon, Yvette L; Portlock, Carol S; Wilson, Wyndham H; Goy, Andre; Younes, Anas; Lee, Hun Ju

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

霍奇金淋巴瘤的全面基因组分析揭示了反复突变的基因和增加的突变负荷

Liang, Winnie S; Vergilio, Jo-Anne; Salhia, Bodour; Huang, Helen J; Oki, Yasuhiro; Garrido-Laguna, Ignacio; Park, Haeseong; Westin, Jason R; Meric-Bernstam, Funda; Fabrizio, David; Miller, Vincent A; Stephens, Philip J; Fanale, Michelle A; Ross, Jeffrey S; Janku, Filip

Lenalidomide plus rituximab (R(2) ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial

来那度胺联合利妥昔单抗(R(2))治疗既往未接受治疗的边缘区淋巴瘤:一项开放标签 II 期试验的亚组分析和长期随访

Becnel, Melody R; Nastoupil, Loretta J; Samaniego, Felipe; Davis, Richard E; You, M J; Green, Michael; Hagemeister, Fredrick B; Fanale, Michelle A; Fayad, Luis E; Westin, Jason R; Wang, Michael; Oki, Yasuhiro; Forbes, Sheryl G; Feng, Lei; Neelapu, Sattva S; Fowler, Nathan H

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

Brentuximab Vedotin联合化疗治疗III期或IV期霍奇金淋巴瘤

Connors, Joseph M; Jurczak, Wojciech; Straus, David J; Ansell, Stephen M; Kim, Won S; Gallamini, Andrea; Younes, Anas; Alekseev, Sergey; Illés, Árpád; Picardi, Marco; Lech-Maranda, Ewa; Oki, Yasuhiro; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J; Bartlett, Nancy L; Walewski, Jan; Chen, Robert; Ramchandren, Radhakrishnan; Zinzani, Pier L; Cunningham, David; Rosta, Andras; Josephson, Neil C; Song, Eric; Sachs, Jessica; Liu, Rachael; Jolin, Hina A; Huebner, Dirk; Radford, John